142 related articles for article (PubMed ID: 22584327)
21. [A case of hypopharyngeal cancer successfully treated with concurrent S-1, nedaplatin and radiotherapy].
Akiyama R; Shimane T; Kobayashi S; Ikeda K; Egawa S; Ikenoya Y; Uzuki A; Sugimoto A; Hayashi T; Sanbe T
Gan To Kagaku Ryoho; 2011 Apr; 38(4):631-3. PubMed ID: 21498993
[TBL] [Abstract][Full Text] [Related]
22. [The clinical effect of combination therapy for oral cancer with S-1, superselective intra-arterial chemotherapy, and radiation therapy].
Yamamoto C; Yoshikawa H; Fukumoto S; Higuchi T; Yoshida M; Horinouchi Y; Uehara S; Yasumori K
Gan To Kagaku Ryoho; 2011 Dec; 38(13):2575-8. PubMed ID: 22189221
[TBL] [Abstract][Full Text] [Related]
23. Squamous cell carcinoma of the hypopharynx: single-institution outcome analysis of a large cohort of patients treated with primary non-surgical approaches.
Gupta T; Chopra S; Agarwal JP; Laskar SG; D'cruz AK; Shrivastava SK; Dinshaw KA
Acta Oncol; 2009; 48(4):541-48. PubMed ID: 18979267
[TBL] [Abstract][Full Text] [Related]
24. Chemoradiation therapy with or without salvage surgery for early squamous cell carcinoma of the hypopharynx.
Nakamura K; Shioyama Y; Sasaki T; Ohga S; Saku M; Urashima Y; Yoshitake T; Nakashima T; Kuratomi Y; Komune S; Terashima H; Honda H
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):680-3. PubMed ID: 15936545
[TBL] [Abstract][Full Text] [Related]
25. Induction chemotherapy with S-1 plus cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck.
Choi YJ; Chung JS; Shin HJ; Cho GJ; Wang SG; Lee BJ; Cho BM; Joo YD; Sohn CH
J Laryngol Otol; 2008 Aug; 122(8):848-53. PubMed ID: 18047761
[TBL] [Abstract][Full Text] [Related]
26. Non-surgical multimodality treatment for locally advanced (T3-4) hypopharyngeal cancer: the impact of pre-treatment hemoglobin level.
Suzuki G; Ogo E; Abe T; Hayabuchi N; Umeno H; Nakashima T; Yamazaki H; Nakamura S; Yoshida K
Anticancer Res; 2013 Dec; 33(12):5561-5. PubMed ID: 24324098
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.
Chang PM; Chen PM; Chu PY; Wang LW; Tai SK; Tsai TL; Huang JL; Wang YF; Chang SY; Yang MH
Cancer Chemother Pharmacol; 2008 Dec; 63(1):9-17. PubMed ID: 18343925
[TBL] [Abstract][Full Text] [Related]
28. Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy.
Chan AK; Wong A; Jenken D; Heine J; Buie D; Johnson D
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):665-77. PubMed ID: 15708244
[TBL] [Abstract][Full Text] [Related]
29. Organ preservation with concurrent chemoradiation for advanced laryngeal cancer: are we succeeding?
Lambert L; Fortin B; Soulières D; Guertin L; Coulombe G; Charpentier D; Tabet JC; Bélair M; Khaouam N; Nguyen-Tan PF
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):398-402. PubMed ID: 19394155
[TBL] [Abstract][Full Text] [Related]
30. [Induction chemotherapy and larynx preservation: is such practice useful?].
Sarini J; Bocciolini C; Fournier C; Penel N; Kara A; Van JT; Lefebvre JL
Bull Cancer; 2002 Apr; 89(4):411-7. PubMed ID: 12016041
[TBL] [Abstract][Full Text] [Related]
31. Concurrent chemoradiotherapy with cisplatin and fluorouracil for locally advanced hypopharyngeal carcinoma.
Yoon MS; Chung WK; Ahn SJ; Nam TK; Nah BS; Song JY; Lim SC; Lee JK
Acta Otolaryngol; 2008 May; 128(5):590-6. PubMed ID: 18421617
[TBL] [Abstract][Full Text] [Related]
32. Predisposing factors for larynx preservation strategies with non-surgical multimodality treatment for locally advanced (T3-4) larynx, hypopharynx and cervical esophageal disease.
Suzuki G; Yamazaki H; Ogo E; Abe T; Eto H; Muraki K; Hattori C; Umeno H; Tanaka N; Tanaka T; Nakamura S; Yoshida K
Anticancer Res; 2014 Sep; 34(9):5205-10. PubMed ID: 25202116
[TBL] [Abstract][Full Text] [Related]
33. Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.
Majem M; Mesia R; Mañós M; Gomez J; Galiana R; Cardenal F; Juan A; Montes A; Perez FJ; Nogues J; Llluch JR
Laryngoscope; 2006 Sep; 116(9):1651-6. PubMed ID: 16954998
[TBL] [Abstract][Full Text] [Related]
34. Accelerated radiotherapy and larynx preservation in favorable-risk patients with T2 or worse hypopharyngeal cancer.
Kawashima M; Hayashi R; Tahara M; Yamazaki M; Miyazaki M; Arahira S; Ogino T
Jpn J Clin Oncol; 2007 May; 37(5):345-52. PubMed ID: 17584824
[TBL] [Abstract][Full Text] [Related]
35. Hypopharyngeal cancer treatment based on definitive radiotherapy: who is suitable for laryngeal preservation?
Chen SW; Tsai MH; Yang SN; Liang JA; Shiau AC; Lin FJ
J Laryngol Otol; 2008 May; 122(5):506-12. PubMed ID: 17931444
[TBL] [Abstract][Full Text] [Related]
36. [Combined treatment of hypopharyngeal carcinoma].
Düring A; Sauer R; Steiner W; Herbst M; Reul H
Strahlenther Onkol; 1987 Dec; 163(12):764-73. PubMed ID: 3424076
[TBL] [Abstract][Full Text] [Related]
37. Outcomes in patients with early-stage hypopharyngeal cancer treated with radiotherapy.
Yoshimura R; Kagami Y; Ito Y; Asai M; Mayahara H; Sumi M; Itami J
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1017-23. PubMed ID: 19910141
[TBL] [Abstract][Full Text] [Related]
38. Multi-institutional analysis of early squamous cell carcinoma of the hypopharynx treated with radical radiotherapy.
Nakamura K; Shioyama Y; Kawashima M; Saito Y; Nakamura N; Nakata K; Hareyama M; Takada T; Karasawa K; Watanabe T; Yorozu A; Tachibana H; Suzuki G; Hayabuchi N; Toba T; Yamada S
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1045-50. PubMed ID: 16682142
[TBL] [Abstract][Full Text] [Related]
39. [Clinical study and survival analysis of combined modality therapies for advanced hypopharyngeal carcinoma].
Shi Q; Li W; Li G; Zhang C; Fang X; Wu L; Zhang L; Liao Z
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Feb; 27(4):206-9. PubMed ID: 23631137
[TBL] [Abstract][Full Text] [Related]
40. [Preservation of laryngeal function in surgical treatment of hypopharyngeal carcinoma].
Wang T; Li X; Yu Z
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1999 Aug; 34(4):197-200. PubMed ID: 12764769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
